Stay updated with breaking news from Optimizing Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death. Investigators compared analog and human insulin and major outcomes in patients with type 2 diabetes receiving hemodialysis.
Closing out their discussion on renal cell carcinoma, key opinion leaders highlight the value of multidisciplinary care and look toward future evolutions in the treatment paradigm.
Expert panelists highlight aspects of a final patient scenario, discussing adjuvant treatment strategies in the setting of renal cell carcinoma at intermediate-high risk for recurrence.
/PRNewswire/ -- Dr. Kiya Movassaghi, Founder and Director of Movassaghi Plastic Surgery & Ziba Medical Spa in Eugene, Oregon, was recently chosen by his...
Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.